Symptoms of overdose include bleeding in the eye or redness or swelling of the eye or the eyelid, blurred vision or other change in vision, fever or chills, itching or tearing, nausea or vomiting, pain, sensitivity to light, shortness of breath, sticky or matted eyelashes, swelling of face, throbbing pain, tightness in chest, troubled breathing, and wheezing.
An ibuprofen-type anti-inflammatory analgesic and antipyretic. It inhibits prostaglandin synthesis and has been proposed as an anti-arthritic. It is no longer approved for use in the United States.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Aminosalicylic acid | The therapeutic efficacy of Aminosalicylic acid can be decreased when used in combination with Suprofen. |
| Mesalazine | The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Suprofen. |
| Sulfasalazine | The therapeutic efficacy of Sulfasalazine can be decreased when used in combination with Suprofen. |
| Diflunisal | The therapeutic efficacy of Diflunisal can be decreased when used in combination with Suprofen. |
| Acetylsalicylic acid | The therapeutic efficacy of Acetylsalicylic acid can be decreased when used in combination with Suprofen. |
| Balsalazide | The therapeutic efficacy of Balsalazide can be decreased when used in combination with Suprofen. |
| Olsalazine | The risk or severity of nephrotoxicity can be increased when Suprofen is combined with Olsalazine. |
| Bismuth subsalicylate | The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Suprofen. |
| Dersalazine | The therapeutic efficacy of Dersalazine can be decreased when used in combination with Suprofen. |
| Phenyl aminosalicylate | The therapeutic efficacy of Phenyl aminosalicylate can be decreased when used in combination with Suprofen. |
| Methyl salicylate | The therapeutic efficacy of Methyl salicylate can be decreased when used in combination with Suprofen. |
| Trolamine salicylate | The therapeutic efficacy of Trolamine salicylate can be decreased when used in combination with Suprofen. |
| Nitroaspirin | The therapeutic efficacy of Nitroaspirin can be decreased when used in combination with Suprofen. |
| Aloxiprin | The therapeutic efficacy of Aloxiprin can be decreased when used in combination with Suprofen. |
| Guacetisal | The therapeutic efficacy of Guacetisal can be decreased when used in combination with Suprofen. |
| Carbaspirin calcium | The therapeutic efficacy of Carbaspirin calcium can be decreased when used in combination with Suprofen. |
| Choline salicylate | The therapeutic efficacy of Choline salicylate can be decreased when used in combination with Suprofen. |
| Thiosalicylic acid | The therapeutic efficacy of Thiosalicylic acid can be decreased when used in combination with Suprofen. |
| Diclofenac | The risk or severity of adverse effects can be increased when Diclofenac is combined with Suprofen. |
| Flurbiprofen | The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Suprofen. |
| Bromfenac | The risk or severity of adverse effects can be increased when Suprofen is combined with Bromfenac. |
| Nepafenac | The risk or severity of adverse effects can be increased when Suprofen is combined with Nepafenac. |
| Indomethacin | The risk or severity of adverse effects can be increased when Indomethacin is combined with Suprofen. |
| Nabumetone | The risk or severity of adverse effects can be increased when Nabumetone is combined with Suprofen. |
| Tenoxicam | The risk or severity of adverse effects can be increased when Tenoxicam is combined with Suprofen. |
| Celecoxib | The risk or severity of adverse effects can be increased when Celecoxib is combined with Suprofen. |
| Tolmetin | The risk or severity of adverse effects can be increased when Tolmetin is combined with Suprofen. |
| Rofecoxib | The risk or severity of adverse effects can be increased when Rofecoxib is combined with Suprofen. |
| Piroxicam | The risk or severity of adverse effects can be increased when Piroxicam is combined with Suprofen. |
| Fenoprofen | The risk or severity of adverse effects can be increased when Fenoprofen is combined with Suprofen. |
| Valdecoxib | The risk or severity of adverse effects can be increased when Valdecoxib is combined with Suprofen. |
| Sulindac | The risk or severity of adverse effects can be increased when Sulindac is combined with Suprofen. |
| Etodolac | The risk or severity of adverse effects can be increased when Etodolac is combined with Suprofen. |
| Mefenamic acid | The risk or severity of adverse effects can be increased when Mefenamic acid is combined with Suprofen. |
| Naproxen | The risk or severity of adverse effects can be increased when Naproxen is combined with Suprofen. |
| Phenylbutazone | The risk or severity of adverse effects can be increased when Phenylbutazone is combined with Suprofen. |
| Meloxicam | The risk or severity of adverse effects can be increased when Meloxicam is combined with Suprofen. |
| Carprofen | The risk or severity of adverse effects can be increased when Carprofen is combined with Suprofen. |
| Salicylic acid | The risk or severity of adverse effects can be increased when Suprofen is combined with Salicylic acid. |
| Meclofenamic acid | The risk or severity of adverse effects can be increased when Suprofen is combined with Meclofenamic acid. |
| Oxaprozin | The risk or severity of adverse effects can be increased when Suprofen is combined with Oxaprozin. |
| Ketoprofen | The risk or severity of adverse effects can be increased when Suprofen is combined with Ketoprofen. |
| Ibuprofen | The risk or severity of adverse effects can be increased when Suprofen is combined with Ibuprofen. |
| Lumiracoxib | The risk or severity of adverse effects can be increased when Suprofen is combined with Lumiracoxib. |
| Magnesium salicylate | The risk or severity of adverse effects can be increased when Suprofen is combined with Magnesium salicylate. |
| Salsalate | The risk or severity of adverse effects can be increased when Suprofen is combined with Salsalate. |
| Choline magnesium trisalicylate | The risk or severity of adverse effects can be increased when Suprofen is combined with Choline magnesium trisalicylate. |
| Antipyrine | The risk or severity of adverse effects can be increased when Suprofen is combined with Antipyrine. |
| Tiaprofenic acid | The risk or severity of adverse effects can be increased when Suprofen is combined with Tiaprofenic acid. |
| Etoricoxib | The risk or severity of adverse effects can be increased when Suprofen is combined with Etoricoxib. |
| Oxyphenbutazone | The risk or severity of adverse effects can be increased when Suprofen is combined with Oxyphenbutazone. |
| Niflumic acid | The risk or severity of adverse effects can be increased when Suprofen is combined with Niflumic acid. |
| Nimesulide | The risk or severity of adverse effects can be increased when Suprofen is combined with Nimesulide. |
| Benoxaprofen | The risk or severity of adverse effects can be increased when Suprofen is combined with Benoxaprofen. |
| Zomepirac | The risk or severity of adverse effects can be increased when Suprofen is combined with Zomepirac. |
| Lornoxicam | The risk or severity of adverse effects can be increased when Suprofen is combined with Lornoxicam. |
| Aceclofenac | The risk or severity of adverse effects can be increased when Suprofen is combined with Aceclofenac. |
| Zaltoprofen | The risk or severity of adverse effects can be increased when Suprofen is combined with Zaltoprofen. |
| Azapropazone | The risk or severity of adverse effects can be increased when Suprofen is combined with Azapropazone. |
| Felbinac | The risk or severity of adverse effects can be increased when Suprofen is combined with Felbinac. |
| Parecoxib | The risk or severity of adverse effects can be increased when Suprofen is combined with Parecoxib. |
| Salicylamide | The risk or severity of adverse effects can be increased when Suprofen is combined with Salicylamide. |
| Kebuzone | The risk or severity of adverse effects can be increased when Suprofen is combined with Kebuzone. |
| Isoxicam | The risk or severity of adverse effects can be increased when Suprofen is combined with Isoxicam. |
| Indoprofen | The risk or severity of adverse effects can be increased when Suprofen is combined with Indoprofen. |
| Ibuproxam | The risk or severity of adverse effects can be increased when Suprofen is combined with Ibuproxam. |
| Floctafenine | The risk or severity of adverse effects can be increased when Suprofen is combined with Floctafenine. |
| Fenbufen | The risk or severity of adverse effects can be increased when Suprofen is combined with Fenbufen. |
| Etofenamate | The risk or severity of adverse effects can be increased when Suprofen is combined with Etofenamate. |
| Epirizole | The risk or severity of adverse effects can be increased when Suprofen is combined with Epirizole. |
| Loxoprofen | The risk or severity of adverse effects can be increased when Suprofen is combined with Loxoprofen. |
| Droxicam | The risk or severity of adverse effects can be increased when Suprofen is combined with Droxicam. |
| Tolfenamic acid | The risk or severity of adverse effects can be increased when Suprofen is combined with Tolfenamic acid. |
| Clonixin | The risk or severity of adverse effects can be increased when Suprofen is combined with Clonixin. |
| Propacetamol | The risk or severity of adverse effects can be increased when Suprofen is combined with Propacetamol. |
| Tepoxalin | The risk or severity of adverse effects can be increased when Suprofen is combined with Tepoxalin. |
| Flunixin | The risk or severity of adverse effects can be increased when Suprofen is combined with Flunixin. |
| Indobufen | The risk or severity of adverse effects can be increased when Suprofen is combined with Indobufen. |
| Tinoridine | The risk or severity of adverse effects can be increased when Suprofen is combined with Tinoridine. |
| Alclofenac | The risk or severity of adverse effects can be increased when Suprofen is combined with Alclofenac. |
| Fentiazac | The risk or severity of adverse effects can be increased when Suprofen is combined with Fentiazac. |
| Suxibuzone | The risk or severity of adverse effects can be increased when Suprofen is combined with Suxibuzone. |
| Bumadizone | The risk or severity of adverse effects can be increased when Suprofen is combined with Bumadizone. |
| Alminoprofen | The risk or severity of adverse effects can be increased when Suprofen is combined with Alminoprofen. |
| Bufexamac | The risk or severity of adverse effects can be increased when Suprofen is combined with Bufexamac. |
| Feprazone | The risk or severity of adverse effects can be increased when Suprofen is combined with Feprazone. |
| Difenpiramide | The risk or severity of adverse effects can be increased when Suprofen is combined with Difenpiramide. |
| Nifenazone | The risk or severity of adverse effects can be increased when Suprofen is combined with Nifenazone. |
| Lonazolac | The risk or severity of adverse effects can be increased when Suprofen is combined with Lonazolac. |
| Tenidap | The risk or severity of adverse effects can be increased when Suprofen is combined with Tenidap. |
| Bendazac | The risk or severity of adverse effects can be increased when Suprofen is combined with Bendazac. |
| Pranoprofen | The risk or severity of adverse effects can be increased when Suprofen is combined with Pranoprofen. |
| Propyphenazone | The risk or severity of adverse effects can be increased when Suprofen is combined with Propyphenazone. |
| Proglumetacin | The risk or severity of adverse effects can be increased when Suprofen is combined with Proglumetacin. |
| Ethenzamide | The risk or severity of adverse effects can be increased when Suprofen is combined with Ethenzamide. |
| Mofebutazone | The risk or severity of adverse effects can be increased when Suprofen is combined with Mofebutazone. |
| Proquazone | The risk or severity of adverse effects can be increased when Suprofen is combined with Proquazone. |
| Benorilate | The risk or severity of adverse effects can be increased when Suprofen is combined with Benorilate. |
| Pirprofen | The risk or severity of adverse effects can be increased when Suprofen is combined with Pirprofen. |
| Acemetacin | The risk or severity of adverse effects can be increased when Suprofen is combined with Acemetacin. |